Central Pharmaceutical Joint Stock Company No. 3 announced earnings results for the fourth quarter ended December 31, 2019. For the fourth quarter, the company announced total revenue was VND 98,228.762 million compared to VND 109,571.000 million a year ago. Operating income was VND 5,716.352 million compared to operating loss of VND 1,550.739 million a year ago. Net income was VND 4,588.229 million compared to net loss of VND 4,225.681 million a year ago. Basic earnings per share was VND 522 compared to basic loss per share of VND 578 a year ago. For the full year, total revenue was VND 411,433.000 million compared to VND 471,177.000 million a year ago. Operating income was VND 105,344.000 million compared to VND 101,797.000 million a year ago. Net income was VND 82,804.419 million compared to VND 80,063.344 million a year ago. Basic earnings per share was VND 9,419 compared to VND 10,950 a year ago.